February 2023 Publications
- The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline. Frost I, Sati H, Garcia-Vello P, Hasso-Agopsowicz M, Lienhardt C, Gigante V, Beyer P. Lancet Microbe. 2023 Feb. doi: 10.1016/S2666-5247(22)00303-2. Epub 2022 Dec 14.
- Characterization of natural killer cells in the blood and airways of cynomolgus macaques during Mycobacterium tuberculosis infection. Diedrich CR, Rutledge T, Baranowski TM, Maiello P, Lin PL. J Med Primatol. 2023 Feb. doi: 10.1111/jmp.12617. Epub 2022 Sep 3.
- Surveillance of Daughter Micronodule Formation Is a Key Factor for Vaccine Evaluation Using Experimental Infection Models of Tuberculosis in Macaques. Nogueira I, Català M, White AD, Sharpe SA, Bechini J, Prats C, Vilaplana C, Cardona P. Pathogens. 2023 Feb 2. doi: 10.3390/pathogens12020236.
- Mycobacterium tuberculosis Evasion of Guanylate Binding Protein-Mediated Host Defense in Mice Requires the ESX1 Secretion System. Olive AJ, Smith CM, Baer CE, Coers J, Sassetti CM. Int J Mol Sci. 2023 Feb 2. doi: 10.3390/ijms24032861.
- Report of 16 Years of the BCG Vaccine under the Expanded Program on Immunizations in Mexico (2006-2021). Romero-Feregrino R, Romero-Cabello R, Rodríguez-León MA, Romero-Feregrino R, Muñoz-Cordero B, Aguilar-Feregrino JI. Vaccines (Basel). 2023 Feb 2. doi: 10.3390/vaccines11020337.
- Finding TB vaccine antigens: follow the TCRs. Lichtman A. Sci Immunol. 2023 Feb 3. doi: 10.1126/sciimmunol.adg8281. Epub 2023 Feb 3.
- Pulmonary Administration of the Liposome-Based Adjuvant CAF01: Effect of Surface Charge on Mucosal Adjuvant Function. Müllertz OAO, Andersen P, Christensen D, Foged C, Thakur A. Mol Pharm. 2023 Feb 6. doi: 10.1021/acs.molpharmaceut.2c00634. Epub 2022 Dec 30.
- Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice. Kirk NM, Huang Q, Vrba S, Rahman M, Block AM, Murphy H, White DW, Namugenyi SB, Ly H, Tischler AD, Liang Y. Front Immunol. 2023 Feb 8. doi: 10.3389/fimmu.2023.1127515. eCollection 2023
- Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19. Gong W, Xie J, Li H, Aspatwar A. Front Immunol. 2023 Feb 9. doi: 10.3389/fimmu.2023.1147704. eCollection 2023.
- Preclinical developments in the delivery of protein antigens for vaccination. Hendy DA, Haven A, Bachelder EM, Ainslie KM. Expert Opin Drug Deliv. 2023 Feb 10. doi: 10.1080/17425247.2023.2176844. Online ahead of print.
- BCG-induced trained immunity: history, mechanisms and potential applications. Chen J, Gao L, Wu X, Fan Y, Liu M, Peng L, Song J, Li B, Liu A, Bao F. J Transl. Med. 2023 Feb 10. doi: 10.1186/s12967-023-03944-8.
- Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c. D’Auria G, Hodzhev Y, Aceves-Sánchez MJ, Moya A, Panaiotov S, Flores-Valdez MA. BMC Genomics. 2023 Feb 10. doi: 10.1186/s12864-023-09169-9.
- Design of multi-epitope based vaccine against Mycobacterium tuberculosis: a subtractive proteomics and reverse vaccinology based immunoinformatics approach. Nayak SS, Sethi G, Ramadas K. J Biomol Struct Dyn. 12 Feb 2023. doi: 10.1080/07391102.2023.2178511. Online ahead of print.
- Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells. Wang Y, Ge F, Wang J, Li H, Zheng B, Li W, Chen S, Zheng X, Deng Y, Wang Y, Zeng R. J Virol. 2023 Feb 13. doi: 10.1128/jvi.01764-22. Online ahead of print.
- Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection. Liang Y, Li X, Yang Y, Xiao L, Liang Y, Mi J, Xue Y, Gong W, Wang L, Wang J, Zhang J, Shi Y, Peng B, Chen X, Zhao W, Wu X. Front Immunol. 2023 Feb 13. doi: 10.3389/fimmu.2023.1110843.
- A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase TB Trials. Kurbatova EV, Phillips PP, Dorman SE, Sizemore EE, Bryant KE, Purfield AE, Ricaldi J, Brown NE, Johnson JL, Wallis CL, Akol JP, Ocheretina O, Hung NV, Mayanja-Kizza H, Lourens M, Dawson R, Nhung NV, Pierre S, Musodza Y, Shenje J, Badal-Faesen S, Vilbrun SC, Waja Z, Peddareddy L, Scott NA, Yuan Y, Vernon A, Goldberg SV, Swindells S, Chaisson RE, Nahid P, AIDS Clinical Trials Group and the Tuberculosis Trials Consortium. AM J Respir Crit Care Med. 2023 Feb 15. doi: 10.1164/rccm.202206-1118OC. Online ahead of print.
- Meeting Summary: Global Vaccine and Immunization Research Forum, 2021. Ford A, Hwang A, Mo AX, Baqar S, Touchette N, Deal C, King D, Earle K, Giersing B, Dull P, Hall BF. Vaccine. 2023 Feb 18. doi: 10.1016/j.vaccine.2023.02.028. Online ahead of print.
- Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG. Mao L, Du J, Wang X, Xu L, Zhang Y, Sun Q, Shi Z, Xing Y, Su Y, Wang S, Wang J, Ma J, Zhang J. ACS Infect Dis. 2023 Feb 21. doi: 10.1021/acsinfecdis.2c00570. Online ahead of print.
- Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice. Afkhami S, D’Agostino MR, Vaseghi-Shanjani M, Lepard M, Yang JX, Lai R, Wa Yan Choi M, Chacon A, Zganiacz A, Franken KLMC, Ertl HE, Ottenhoff THM, Jeyanathan M, Gillgrass A, Xing Z. NPJ Vaccines. 2023 Feb 23. doi: 10.1038/s41541-023-00623-z.
- Newborn BCG vaccination induces robust infant IFNγ-expressing NK cell responses to mycobacteria. Murphy M, Suliman S, Briel L, Veldtsman H, Khomba N, Africa H, Steyn M, Snyders CI, van Rensburg IC, Walzl G, Chegou NN, Hatherill M, Hanekom WA, Scriba TJ, Nemes E. Int J Infect Dis. 2023 Feb 24. doi: 10.1016/j.ijid.2023.02.018. Online ahead of print.
- Safety and efficacy of tuberculosis vaccine candidates in low– and middle-income countries: a systematic review of randomized controlled clinical trials. Wilson L, Gracie L, Kidy F, Thomas GN, Nirantharakumar K, Greenfield S, Manaseki-Holland S, Ward, DJ, Gooden, TE. BMC Infec Dis. 2023 Feb 24. doi: 10.1186/s12879-023-08092-4.
- New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination. Weerasuriya CK, Portnoy A, Mukandavire C, Quaife M, Bakker R, Scarponi D, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. medRxiv. 2023 Feb 24. doi: 10.1101/2023.02.24.23286406. Preprint
- Antibodies Targeting the Cell Wall Induce Protection against Virulent Mycobacterium bovis Infection. Qu M, Liang Z, Chen Y, Wang Y, Wang H, Liu Z, Liu Y, Dong Y, Ge X, Li H, Zhou X. Microbiol Spectr. 2023 Feb 27. doi: 10.1128/spectrum.03431-22. Online ahead of print.
- A MAPS Vaccine Induces Multipronged Systemic and Tissue-Resident Cellular Responses and Protects Mice against Mycobacterium tuberculosis. O’Hara JM, Wakabayashi S, Siddiqi N, Cheung E, Babunovic GH, Thompson CM, Lu Y, Rubin EJ, Malley R, Zhang F. mBio. 2023 Feb 28. doi: 10.1128/mbio.03611-22.
- Spotlight on mycobacterial lipid exploitation using nanotechnology for diagnosis, vaccines, and treatments. Valdemar-Aguilar CM, Manisekaran R, Acosta-Torres LS, López-Marín LM. Nanomedicine. 2023 Feb. doi: 10.1016/j.nano.2023.